Back
Editas Medicine Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Sell
40
EDIT
Editas Medicine
Last Price:
3.92
Seasonality Move:
2.24%
Buy
64
REGN
Regeneron Pharmaceuticals
Last Price:
1,150.22
Seasonality Move:
4.55%
Sell
40
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
- The current Editas Medicine [EDIT] share price is $3.87. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $1,138.81. The Score for REGN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $3.87
The current trend is relatively stagnant and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $1,138.81
The current trend is relatively stagnant and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
EDIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 47.5 | Sell |
| Chaikin Money Flow: | -2434195 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.61 - 3.97) | Buy |
| Bollinger Bands (100): | (4.12 - 5.64) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.87 | Buy |
| Relative Strength Index (14 RSI): | 46.33 | Sell |
| Chaikin Money Flow: | -285928 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1147.52 - 1192.36) | Sell |
| Bollinger Bands (100): | (981.52 - 1142.74) | Buy |
EDIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.79 | Buy |
| 20-day SMA: | 3.75 | Buy |
| 50-day SMA: | 4.44 | Sell |
| 200-day SMA: | 6.62 | Sell |
| 8-day EMA: | 3.8 | Buy |
| 20-day EMA: | 3.85 | Buy |
| 50-day EMA: | 4.27 | Sell |
| 200-day EMA: | 6.06 | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1147.4 | Sell |
| 20-day SMA: | 1167.39 | Sell |
| 50-day SMA: | 1127.19 | Buy |
| 200-day SMA: | 993.61 | Buy |
| 8-day EMA: | 1149.58 | Sell |
| 20-day EMA: | 1153.25 | Sell |
| 50-day EMA: | 1126.06 | Buy |
| 200-day EMA: | 1007.12 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.68 per share, and an increase next year of $0.17 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.99 per share, an increase next quarter of $1.60 per share, an increase this year of $2.56 per share, and an increase next year of $3.90 per share.
Editas Medicine Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||